Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

The triple rotation scalp flap technique successfully reconstructed a man's scalp with natural-looking hair growth and minimal scarring.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Severe hair loss may increase the risk of dying from COVID-19.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

About 61% of women who had COVID-19 experienced hair loss afterward.

Early diagnosis, decontamination, and supportive care are crucial for managing acute radiation syndrome.

Thyroid storm is hard to diagnose due to vague symptoms but needs urgent attention.

Recognizing lupus as a cause of severe gut issues is crucial for effective treatment.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Frontalis suspension surgery using autologous fascia lata is effective for treating unilateral congenital ptosis with poor levator function.

New treatments using stem cells and special materials show promise for severe eye surface disease.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.